Deventer Sander van Insider Trading
Get free email notifications about insider trading for Deventer Sander van.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deventer Sander van. Deventer Sander van is a Director in ARGOS THERAPEUTICS INC ($ARGS) and a Chief Scientific Officer in uniQure N.V. ($QURE) and a Director in uniQure N.V. ($QURE) and a EVP, Research & Product Dev. in uniQure N.V. ($QURE) and a Director in HOOKIPA Pharma Inc. ($HOOK).
Address: C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 1411 DC NAARDEN Netherlands
Companies in which Deventer Sander van is an Insider
ARGOS THERAPEUTICS INC
Trading Symbol: ARGSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deventer Sander van: Director
Holdings: 5,057 shares
Current Value: $24,526
Latest Transaction: Jan 20 2017
$ARGS Market Capitalization: $208.29M
$ARGS Previous Close: $4.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HOOKIPA Pharma Inc.
Trading Symbol: HOOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deventer Sander van: Director
Holdings: 2,485 shares
Latest Transaction: Oct 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
uniQure N.V.
Trading Symbol: QUREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deventer Sander van: EVP, Research & Product Dev., Chief Scientific Officer, Director
Holdings: 61,599 shares
Current Value: $392,386
Latest Transaction: Mar 02 2020
$QURE Market Capitalization: $165.39M
$QURE Previous Close: $6.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Deventer Sander van
Sentiment: All, ARGS, HOOK, QURE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 23 2020 | HOOK | HOOKIPA Pharma Inc ... | van Deventer Sander | Director | Grant | A | 0.00 | 2,485 | 0 | 2,485 | 0 to 2.5 K |
Jun 19 2020 | HOOK | HOOKIPA Pharma Inc ... | van Deventer Sander | Director | Option Exercise | A | 11.45 | 9,600 | 109,920 | 9,600 | |
Mar 02 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Option Exercise | A | 51.81 | 21,719 | 1,125,261 | 21,719 | |
Mar 02 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Grant | A | 0.00 | 12,380 | 0 | 61,599 | 49.2 K to 61.6 K (+25.15 %) |
Jan 31 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Grant | A | 0.00 | 6,092 | 0 | 49,219 | 43.1 K to 49.2 K (+14.13 %) |
Jan 30 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Sell | S | 62.10 | 923 | 57,318 | 43,127 | 44.1 K to 43.1 K (-2.10 %) |
Jan 30 2020 | QURE | uniQure N.V. | van Deventer Sander | EVP, Research & Pro ... | Sell | S | 61.27 | 1,304 | 79,896 | 44,050 | 45.4 K to 44.1 K (-2.88 %) |